SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CNSI Cambridge Neuroscience
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
675 9 0 CNSI
Emcee:  Peter R Smith Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
175 NI, Thanks for comment. I have great respects to Dr. Lipton work, in Germany aMiljenko Zuanic-5/28/1997
174 While Lipton has made progress in terms of delineating which excitatory amino aNeuroInvestment-5/28/1997
173 NI, Any comments on article: 198.168.83.161 Thanks.Miljenko Zuanic-5/28/1997
172 Andy, Welcome to thread. Roche acquired BM not BI. Will not effect CNSI-BI rMiljenko Zuanic-5/27/1997
171 Roche just bought Boeringer (sp?). What does this mean for CNSI as I believe tandy harrison-5/27/1997
170 To MZ, and Dr. Tracy: You have sold me on cnsi despite fact NI doesn't ownJoe Wesley-5/23/1997
169 NI, My point was that CNSI and NTII are not "direct" competitors eveMiljenko Zuanic-5/23/1997
168 The neuro sector has recovered somewhat over the past month, but is simply not NeuroInvestment-5/22/1997
167 NTII stock is rallying because Paul Freiman has taken over as CEO and the streeDr. John M. de Castro-5/22/1997
166 My point was not to try to correlate NTII and CNSI price movements. The questiTheSlowLane-5/22/1997
165 Paul, I think that you are wrong when compare price movement between NTII and Miljenko Zuanic-5/21/1997
164 ...and we finish up 1 1/2 on volume of 86,000! Yeah! There have been several TheSlowLane-5/21/1997
163 Thanks for the info, and I hope you will continue to participate on the thread.TheSlowLane-5/21/1997
162 I have published NeuroInvestment since mid-1995. I have a clinical background,(NeuroInvestment-5/21/1997
161 NI, do you publish a newsletter? I just got an excerpt from a newsletter, NeurTheSlowLane-5/20/1997
160 First off Paul thank you very much. Second NeuroInvestment tis appreciated yoAhda-5/20/1997
159 Re: the patent question. I have explored this further, including talking to CNSNeuroInvestment-5/20/1997
158 Darleen, I believe that this will take you there: boston.comTheSlowLane-5/20/1997
157 Paul is there an Url to the Boston Globe? I have a friend totally devoted to CaAhda-5/20/1997
156 While we wait for more info on the patent question... The Boston Globe publishTheSlowLane-5/20/1997
155 NI, Thanks for reply. I do not have ill-tempered altitude toward any poster&Miljenko Zuanic-5/17/1997
154 Mr. Zuanic: Having posted for the first time on this thread a few days ago, I wNeuroInvestment-5/17/1997
153 Darleen, According to early preclinical hrGGF2 should work well in MS, diabetiMiljenko Zuanic-5/16/1997
152 Miljenko I wrote the company hopefully they will E MAil me something back in reAhda-5/16/1997
151 To NI: If you can't answer on my question "ambiguity of the patent coMiljenko Zuanic-5/15/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News